New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 7, 2013
09:55 EDTSTEM, CUR, OSIR, ASTM, BTX, GERNSupreme Court turns down appeal over stem cell research, SCOTUSblog says
The Supreme Court turned down an appeal by scientists seeking to stop all studies on embryonic stem cells, according to SCOTUSblog. The Fly notes that companies engaged in the research, development, and commercialization of stem cell therapies include StemCells (STEM), Neuralstem (CUR), Aastrom Biosciences (ASTM) and Osiris Therapeutics (OSIR). Also, earlier this morning, BioTime (BTX) entered into an agreement to acquire the intellectual property, including patents and patent applications, and other assets related to Geron's (GERN) human embryonic stem cell programs. Reference Link
News For STEM;CUR;OSIR;ASTM;BTX;GERN From The Last 14 Days
Check below for free stories on STEM;CUR;OSIR;ASTM;BTX;GERN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 21, 2014
12:00 EDTASTMAastrom rises 32.7%
Subscribe for More Information
10:00 EDTASTMAastrom rises 26.1%
Aastrom is up 26.1%, or 92c, to $4.44
08:36 EDTASTMAastrom announces definitive agreement to acquire Sanofi's CTRM business
Aastrom Biosciences (ASTM) announced that it has entered into a definitive agreement to acquire Sanofi's (SNY) Cell Therapy and Regenerative Medicine, or CTRM, business for a purchase price of $6.5M, with $4M payable in cash at closing and $2.5M payable in the form of a promissory note. The acquisition is subject to customary closing conditions and is scheduled to close in approximately three weeks. Through the CTRM acquisition, Aastrom is acquiring global commercial rights to three marketed autologous cell therapy products. Aastrom will also acquire global manufacturing and production centers located in the United States and Denmark.
08:32 EDTASTMAastrom announces definitive agreement to acquire Sanofi's CTRM business
08:25 EDTASTMAastrom trading halted, pending news
April 17, 2014
08:05 EDTSTEMStemCells completes enrollment in spinal cord injury trial
Subscribe for More Information
April 16, 2014
09:17 EDTCURNeuralstem spinal cord injury stem cell trial approved to commence in California
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use